InvestorsHub Logo

Investor2014

11/05/23 3:13 PM

#438117 RE: georgejjl #438116

Yet Anavex has failed to date to provide the P2b/3 trial’s baseline to EOS mean ADCS-ADL score - go figure.

One thing this likely tells us is that the P2a Open Label trial was too small to provide reliable results.